Biosimilars to treat inflammatory arthritis: the challenge of proving identity

Ann Rheum Dis. 2013 Oct;72(10):1589-93. doi: 10.1136/annrheumdis-2012-203198. Epub 2013 Jul 29.
No abstract available

Keywords: Ankylosing Spondylitis; Anti-TNF; Pharmacokinetics; Rheumatoid Arthritis; Treatment.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / blood*
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / blood*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Humans
  • Immunoglobulin G / blood*
  • Immunoglobulin G / therapeutic use*
  • Infliximab
  • Male
  • Methotrexate / therapeutic use*
  • Spondylitis, Ankylosing / blood*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin G
  • Infliximab
  • Methotrexate